Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Orphanet Journal of Rare Diseases

Figure 1

From: A generalizable pre-clinical research approach for orphan disease therapy

Figure 1

Normalizing the pathogenic imbalance. Protein levels and/or activity outside of the physiological normal range usually underlie a monogenic disease. Therapeutic approaches may involve normalizing this imbalance by enhancing the mRNA, protein, or protein activity in disorders caused by LOF mutations and moderating the mRNA, protein, or protein function excess observed in GOF mutations.

Back to article page